ライフサイエンスコーパス: vector-borne disease

1 vaccine and treatment are available for this vector-borne disease.

2 ts into the epidemiology and transmission of vector-borne disease.

3 to occur when weather conditions favor this vector-borne disease.

4 logy will have an important role in tackling vector-borne disease.

5 eat strides in reducing the global burden of vector-borne disease.

6 lower global morbidity and mortality due to vector-borne disease.

7 sents a crucial interface in the etiology of vector-borne disease.

8 en the global public health response to this vector-borne disease.

9 novel strategies to eliminate the scourge of vector-borne disease.

10 t could be manipulated as a means to control vector-borne disease.

11 ed mechanism that contributes to severity of vector-borne disease.

12 cal processes that increase the emergence of vector-borne disease.

13 a viable option for the increasing burden of vector-borne disease.

14 pe is equally susceptible to transmission of vector-borne disease.

15 in the effort to control transmission of the vector-borne diseases.

16 olution of alternative transmission modes in vector-borne diseases.

17 developing biological control strategies for vector-borne diseases.

18 of biological control agents in controlling vector-borne diseases.

19 for I. hexagonus, which has implications for vector-borne diseases.

20 ed guard for detecting exotic arthropods and vector-borne diseases.

21 s can help protect children from significant vector-borne diseases.

22 nship between risk factors and prevalence of vector-borne diseases.

23 ene transfer technologies for the control of vector-borne diseases.

24 ically manipulated insects in the control of vector-borne diseases.

25 ion strategy against this and possibly other vector-borne diseases.

26 ms of immunity to Lyme borreliosis and other vector-borne diseases.

27 ces and may be a vaccine target against some vector-borne diseases.

28 mework based on the transmission dynamics of vector-borne diseases.

29 f understanding the ecoepidemiology of these vector-borne diseases.

30 hropogenic changes and associated impacts on vector-borne diseases.

31 alternative for vector control in combating vector-borne diseases.

32 sing means to reduce the burden of pests and vector-borne diseases.

33 alter vector behavior and human exposure to vector-borne diseases.

34 icant threats to public health, particularly vector-borne diseases.

35 croorganisms, hence influencing emergence of vector-borne diseases.

36 on of numerous tropical diseases, especially vector-borne diseases.

37 ector traits that govern the transmission of vector-borne diseases.

38 hich could greatly reduce the burden of many vector-borne diseases.

39 Aedes aegypti mosquitoes released to control vector-borne diseases.

40 availability and can impact transmission of vector-borne diseases.

41 our method can be applied to other arthropod vector-borne diseases.

42 otic diseases, antimicrobial resistance, and vector-borne diseases.

43 aking them promising targets for controlling vector-borne diseases.

44 as a persistent threat to the fight against vector-borne diseases.

45 ust intensify efforts to prevent and control vector-borne diseases.

46 eat promise in reducing the global burden of vector-borne diseases.

47 rolithiasis, renal injury and infectious and vector-borne diseases.

48 focus control efforts in high-risk areas for vector-borne diseases.

49 pecific pathogens and limit the incidence of vector-borne diseases.

50 rence-based technologies to combat pests and vector-borne diseases.

51 ellents, thereby offering protection against vector-borne diseases.

52 ptors could be novel targets for controlling vector-borne diseases.

53 elopment of integrated approaches to control vector-borne diseases.

54 oorganism manipulation approaches to control vector-borne diseases.

55 ration when developing strategies to control vector-borne diseases.

56 play a role in controlling malaria and other vector-borne diseases.

57 n = 169) emphasised the increasing threat of vector-borne diseases.

58 e and constitutes a promising weapon against vector-borne diseases.

59 upt ecosystems, altering the transmission of vector-borne diseases.

60 a key to finding new strategies to eliminate vector-borne diseases.

61 endectocide, which reduces the incidence of vector-borne diseases.

62 flies (Simuliidae) and combating associated vector-borne diseases.

63 vectors, and hence the subsequent control of vector-borne diseases.

64 enting these emerging anaphylactic and other vector-borne diseases.

65 of malaria, dengue, encephalitis, and other vector-borne diseases.

66 tal change that promotes the transmission of vector-borne diseases.

67 reproduction ratio (R(0)) exist for several vector-borne diseases.

68 Yellow fever is a vector-borne disease affecting humans and non-human prim

69 ts a promising new tool in the fight against vector-borne diseases, agricultural pests and invasive s

70 n grid can influence the spatial dynamics of vector borne disease and should be considered when desig

71 to a reevaluation of control strategies for vector-borne disease and be applicable to other disease

72 f evidence for the changing global threat of vector-borne disease and will help decision-makers world

73 the field hold great promise for controlling vector-borne diseases and agricultural pests.

74 ne drives could aid in curbing the spread of vector-borne diseases and controlling crop pest and inva

75 Vector-borne diseases and especially malaria are respons

76 , contributing to the recurrent emergence of vector-borne diseases and its stabilization and exacerba

77 heoretical underpinning of our struggle with vector-borne disease, and still our strongest tool, rema

78 and droughts, changes in the distribution of vector-borne diseases, and effects on the risk of disast

79 impact of Venezuela's health-care crisis on vector-borne diseases, and the spillover into neighbouri

80 d in mortality and fourth in morbidity among vector-borne diseases-and the prominence of the Mediterr

81 Mosquito ecology and the transmission of vector-borne disease are influenced by multiple environm

82 Vector-borne diseases are a heavy burden to human-kind.

83 Vector-borne diseases are a leading cause of death world

84 Emerging vector-borne diseases are an important issue in global h

85 Vector-borne diseases are common in nature and can have

86 omic, behavioral, and institutional factors, vector-borne diseases are complex 'wicked problems'.

87 , control, and evolution of communicable and vector-borne diseases are intimately connected to the jo

88 Vector-borne diseases are on the rise globally.

89 Vector-borne diseases are particularly responsive to cha

90 In Ecuador, vector-borne diseases are present from coastal and Amazo

91 With increasing urbanization vector-borne diseases are quickly developing in cities,

92 Vector-borne diseases are transmitted by haematophagous

93 Vector-borne diseases are worldwide public health issues

94 rch considering impacts of climate change on vector-borne diseases assumes that all populations of a

95 threshold index for epidemicity to models of vector-borne disease because these models have a long hi

96 eases being the largest contributor to human vector-borne disease burden.

97 e disease (LD) is the most commonly reported vector-borne disease, but its clinical consequences rema

98 the prevention, control, and elimination of vector-borne diseases, but insecticide resistance threat

99 Vector-borne diseases can be contracted by exposure to c

100 However, the effects of climate change on vector-borne diseases can be multifaceted and complex, s

101 Vector-borne diseases cause significant financial and hu

102 Emerging and resurging vector-borne diseases cause significant morbidity and mo

103 Human African Trypanosomiasis (HAT) is a vector-borne disease caused by kinetoplastid parasites o

104 Leishmaniasis, a vector-borne disease caused by obligate intramacrophage

105 es including filariasis in eastern Burma and vector-borne diseases (Chagas' disease, leishmaniasis, a

106 expanding the burden of disease from certain vector-borne diseases, climate change represents a major

107 However, the use of DDT to control vector-borne diseases continues in developing countries.

108 Given the large potential benefit to vector-borne disease control, research into the developm

109 cticide resistance is critical for effective vector-borne disease control.

110 proposed program is generally applicable to vector-borne disease control.

111 nge of globally important problems including vector borne disease, crop pests and invasive species.

112 ng the potential to reduce the prevalence of vector-borne diseases, crop pests and non-native invasiv

113 As a common vector-borne disease, dengue fever remains challenging t

114 Vector-borne diseases display wide inter-annual variatio

115 lored as a new strategy in the fight against vector-borne diseases due to their potential for rapidly

116 With the recent resurgence of vector-borne diseases due to urbanization and developmen

117 ented provide a framework to explore spatial vector-borne disease dynamics and control in heterogeneo

118 We develop spatial models of vector-borne disease dynamics on a network of patches to

119 cts, and variation in these traits can shape vector-borne disease dynamics.

120 Yellow fever is a vector-borne disease endemic in tropical regions of Afri

121 lementation of surveillance, particularly in vector-borne disease-endemic areas and in outbreak scena

122 Vector-borne diseases exact a high public health burden

123 Vector-borne diseases exert a considerable toll on globa

124 wo important realities shaping the future of vector-borne disease: first, the genetic-based tools tha

125 answered questions in the realm of bacterial vector-borne disease, focusing on liberibacters, phytopl

126 Management strategies for control of vector-borne diseases, for example Zika or dengue, inclu

127 onotic spillover in recent decades, emerging vector-borne diseases from nonhuman primates pose a sign

128 esentation and zoonotic importance of feline vector-borne diseases (FVBDs).

129 of intervention activities against the fatal vector-borne disease gambiense human African trypanosomi

130 the context of the prevention and control of vector-borne diseases has been broadly described in both

131 For many vector borne diseases, however, two or more vector speci

132 miological shifts with changing climate: (i) vector-borne diseases, (ii) pneumonia and influenza, (ii

133 irds and humans, has emerged as the dominant vector borne disease in North America.

134 idemic LB now constitutes the most important vector borne disease in the United States.

135 Symbiont-linked control of vector-borne disease in Anopheles has been hampered by a

136 ry, an unprecedented change in the status of vector-borne disease in Europe has occurred.

137 mental variables, in studies of peridomestic vector-borne disease in human populations.

138 currently available, is a commonly reported vector-borne disease in North America and Europe.

139 elia burgdorferi, has become the most common vector-borne disease in North America over the last thre

140 Lyme disease is the most prevalent vector-borne disease in North America, and both the annu

141 Lyme borreliosis is the most prevalent vector-borne disease in northern hemisphere.

142 Lyme disease is the most common vector-borne disease in temperate zones and a growing pu

143 Lyme disease (LD) is the most common vector-borne disease in the northern hemisphere and is c

144 Lyme disease is the most common vector-borne disease in the northern hemisphere and is c

145 i sensu lato spirochetes and the most common vector-borne disease in the Northern Hemisphere.

146 Lyme disease (LD) is the most common vector-borne disease in the United States, with 476 000

147 e and distribution to become the most common vector-borne disease in the United States.

148 rial zoonosis, is the most commonly reported vector-borne disease in the United States.

149 Lyme disease is the most common vector-borne disease in the United States.

150 a burgdorferi, is the most commonly reported vector-borne disease in the United States.

151 Lyme disease is the most prevalent vector-borne disease in the US, yet its host factors are

152 d host persistence in the face of introduced vector-borne diseases in Hawaii, where introduced avian

153 g mechanism for the spread of many important vector-borne diseases in humans.

154 originally identified as causative agents of vector-borne diseases in mammals.

155 an urgent need to understand the dynamics of vector-borne diseases in rapidly changing urban environm

156 NCE The emergence and reemergence of various vector-borne diseases in recent years highlights the nee

157 es Lyme disease (LD), one of the most common vector-borne diseases in the Northern Hemisphere.

158 this Review, we summarise the risks posed by vector-borne diseases in the present and the future from

159 t compelling emerging bacterial zoonotic and vector-borne diseases in the United States are Lyme dise

160 Tick-borne infections are the most common vector-borne diseases in the USA.

161 pment of social media, the information about vector-borne disease incidence over broad spatial scales

162 t (such as heat waves) and indirect (such as vector-borne disease incidence) health impacts of climat

163 n half of the world population is at risk of vector-borne diseases including dengue fever, chikunguny

164 climate models shed light upon the spread of vector-borne disease, including Lyme disease in North Am

165 Bacterial vector-borne diseases, including Borrelia species, prese

166 egies can by themselves suffice for managing vector-borne diseases, integrating these approaches beco

167 The incidence of vector-borne disease is on the rise globally, with burde

168 to aid in controlling the growing burden of vector-borne disease is population replacement, in which

169 This vector-borne disease is transmitted by Diaphorina citri,

170 The core of intersectoral action to prevent vector-borne diseases is collaboration among multiple st

171 The transmission of vector-borne diseases is dependent upon the ability of t

172 The impact of blood and its factors on vector-borne diseases is significant and multifaceted ye

173 trategy for the control of malaria and other vector-borne diseases is the introduction into wild vect

174 One method for reducing the impact of vector-borne diseases is through the use of CRISPR-based

175 Dengue fever, a tropical vector-borne disease, is a leading cause of hospitalizat

176 females, can be used in a program to control vector-borne diseases it is essential to understand thei

177 Many vector-borne diseases lack effective vaccines and medica

178 alter the transmission of classically rural, vector-borne diseases like schistosomiasis.

179 s, food scarcity, increases in pollution and vector-borne diseases, lost family income, displacement,

180 Rift Valley fever (RVF) is a zoonotic and vector-borne disease, mainly present in Africa, which re

181 by increasing the risk of water-, food-, and vector-borne diseases, malnutrition, cardiovascular and

182 ion of mosquitoes is a critical component of vector-borne disease management.

183 pulation-engineering solutions for combating vector-borne diseases, managing crop pests, and supporti

184 Cutaneous leishmaniasis (CL) is a vector-borne disease occurred through the bite of sandfl

185 The role of host movement in the spread of vector-borne diseases of livestock has been little studi

186 work is flexible and can be adapted to other vector-borne diseases of livestock.

187 s plays an important role in transmission of vector-borne diseases of public health importance, inclu

188 invasions may help ameliorate the burden of vector-borne diseases on human health.

189 sing valuable mobility patterns for modeling vector-borne diseases outbreaks in cities.

190 In vector-borne diseases, pathogen transmission rate is str

191 his was driven by the high prioritisation of vector-borne diseases (primarily malaria and dengue), tu

192 Surveillance Information System, the Guyana Vector Borne Diseases Program, the Venezuelan Ministry o

193 Leishmaniasis, a vector-borne disease ranked among the six most important

194 ide a new set of armaments in the battle for vector-borne disease reduction.

195 s part of an applied transgenic strategy for vector-borne disease reduction.

196 ENSO was associated more with vector-borne disease [relative risk (RR) 2.96, 95% confi

197 Vector-borne diseases remain a major contributor to the

198 Lyme disease is one of most common vector-borne diseases, reporting more than 300,000 cases

199 The re-emergence of many vector-borne diseases represents a public health crisis

200 Improved control of vector-borne diseases requires an understanding of the m

201 The emergence of new vector-borne diseases requires new methods of vector con

202 riod of substantial scientific growth in the vector-borne disease research community.

203 ate, climate-change adaptation strategies on vector-borne disease risk in the UK.

204 ment models on human health, with a focus on vector-borne disease risk.

205 ventative action and predictive modelling of vector borne disease risks in relation to degradation of

206 aribbean emphasise the need to assess future vector-borne disease risks and prepare contingencies for

207 interplay between human immunocompetence and vector-borne disease risks in a warmer world.

208 o disease vectors, we argue that research on vector-borne diseases should be cross-scale and include

209 Vector-borne disease specialists have traditionally assu

210 ed disease burdens from heat, air pollution, vector-borne diseases, storms, and flooding.

211 rs is a key prerequisite for transmission of vector-borne disease such as avian haemosporidians.

212 mobility is a major factor in the spread of vector-borne diseases such as dengue even on the short s

213 Vector-borne diseases such as malaria and dengue fever c

214 interventions against the ongoing burden of vector-borne diseases such as malaria and dengue.

215 itoes and are of extreme interest to control vector-borne diseases such as malaria.

216 se to be powerful tools in the fight against vector-borne diseases such as malaria.

217 ay be particularly useful for the control of vector-borne diseases such as malaria.

218 are also emerging with the control of 'old' vector-borne diseases such as malaria.

219 imate change, efficient control measures for vector-borne diseases such as this are expected to becom

220 ction is particularly crucial for studies of vector-borne disease, such as Lyme disease, for which ri

221 progress in control of these waterborne and vector-borne diseases, such as guinea worm, schistosomia

222 been employed for studies on the control of vector-borne diseases, such as malaria.

223 panosomiasis ([gHAT] sleeping sickness) is a vector-borne disease that is typically fatal without tre

224 focused on the emergence and reemergence of vector-borne diseases that directly impact the local pop

225 The leishmaniases are vector-borne diseases that have a broad global distribut

226 ize that to fully understand transmission of vector-borne diseases the interaction between the parasi

227 osts or parasites are mobile, for example in vector-borne diseases, the spatial location of infection

228 icidal, thereby providing protection against vector-borne diseases through preventing bites and killi

229 ate mean dispersal distance, of relevance to vector-borne disease transmission and genetic biocontrol

230 ing age dependency in mathematical models of vector-borne disease transmission and in fully understan

231 ate mean dispersal distance, of relevance to vector-borne disease transmission and novel biocontrol s

232 Climate change is already affecting vector-borne disease transmission and spread, and its im

233 ing areas, as well as their direct effect on vector-borne disease transmission are needed to evaluate

234 Here we develop a model for vector-borne disease transmission between mosquitoes and

235 mperature is one of the strongest drivers of vector-borne disease transmission due to its profound ef

236 Vector-borne disease transmission involves complex inter

237 e ability to recognize blood is the basis of vector-borne disease transmission to millions of people

238 ts demonstrate the dynamics of post-disaster vector-borne disease transmission, in the context of con

239 nd urbanization have a significant impact on vector-borne disease transmission, resulting in more sev

240 highlight recent advances in the biology of vector-borne disease transmission, which have translated

241 to disease vectors, and the implications for vector-borne disease transmission.

242 ce our understanding of the role of blood in vector-borne disease transmission.

243 ited States resulting in increased risks for vector-borne disease transmission.

244 Leishmaniasis is a vector-borne disease transmitted by female sand flies in

245 nts an important new approach for monitoring vector-borne disease under climate change.

246 the distribution of 14 vectors of the above vector-borne diseases under present-day and future clima

247 n locations that do not currently experience vector-borne disease (VBD) outbreaks but may be at risk

248 Vector-borne diseases (VBD) challenge our understanding

249 Vector-borne diseases (VBDs) are difficult to prevent an

250 Vector-borne diseases (VBDs) are embedded within complex

251 proaches (MSAs) in prevention and control of vector-borne diseases (VBDs) has been identified.

252 Vector-borne diseases (VBDs) impose devastating effects

253 Preventing vector-borne diseases (VBDs) mainly relies on effective

254 ng global threat of emerging and re-emerging vector-borne diseases (VBDs) poses a serious health prob

255 Vector-borne diseases (VBDs) such as malaria, dengue, an

256 ed by these pathogens, collectively known as vector-borne diseases (VBDs), threaten the health of hum

257 Vector-borne diseases (VBDs), which are caused by pathog

258 ches (MSAs) in the prevention and control of vector-borne diseases (VBDs).

259 0.87) in the Western region; the increase in vector-borne disease was attributable to increased risk

260 To effectively combat vector-borne diseases, we need to determine what is the

261 provision of clean air, protection against a vector-borne disease (West Nile virus), and crop pollina

262 lling framework that can be adapted to other vector-borne diseases with complex host dynamics.

263 80% of the global population is at risk of a vector-borne disease, with mosquito-borne diseases being

264 virus (DENV) is the agent of the most common vector-borne disease worldwide.

265 Malaria is arguably the most serious vector-borne disease worldwide.

266 sole vector of malaria, the most burdensome vector-borne disease worldwide.

267 and dengue, the second most prevalent human vector-borne disease worldwide.

268 the redistribution of vectors and spread of vector-borne diseases worldwide.